Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England

BACKGROUND: The BNT162b2 mRNA vaccine has been shown to be effective at preventing serious COVID-19 events in clinical trials. There is less evidence on effectiveness in real-world settings, especially for older people. Here, we aimed to estimate vaccine effectiveness in the context of the rapid NHS...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, Thomas F. D., Whitston, Matt, Hodgson, Jack, Watkinson, Ruth E., Lau, Yiu-Shing, Abdulrazeg, Omnia, Sutton, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523007/
https://www.ncbi.nlm.nih.gov/pubmed/34663326
http://dx.doi.org/10.1186/s12916-021-02149-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523007/
https://www.ncbi.nlm.nih.gov/pubmed/34663326
http://dx.doi.org/10.1186/s12916-021-02149-4

Ejemplares similares